CRVS Corvus Pharmaceuticals, Inc. logo

CRVS Corvus Pharmaceuticals, Inc.

Healthcare
$12.91+0.00%OpenMarket Cap: $1.09B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

133

13F Shares

46,682,804

Ownership %

56.4%

New Positions

30

Increased Positions

71

Closed Positions

9

Reduced Positions

30

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBCVirtus Biotech Clinical Trials ETF32,5791.33%
CANCTema Oncology ETF107,0730.94%
IDNAiShares Genomics Immunology and Healthcare ETF92,4560.86%
SBIOALPS Medical Breakthroughs ETF68,1940.78%
XBI2,116,8580.41%
SURISimplify Propel Opportunities ETF20,2420.40%
LABUDirexion Daily S&P Biotech Bull 3X ETF105,9500.30%
IJE162,2160.19%
IWCiShares Micro-Cap ETF162,2160.19%
USVM121,1550.12%
VFMO129,8510.08%
IBBiShares Biotechnology ETF473,3260.08%
VTWG52,4120.07%
NLO525,6790.06%
IWOiShares Russell 2000 Growth ETF525,6790.06%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF29,0170.05%
VTWO283,6180.03%
NJM1,567,9220.03%
IWMiShares Russell 2000 ETF1,567,9220.03%
RSSLGlobal X - Russell 2000 ETF26,1360.03%